“Attenuating Renal Interstitial Fibrosis by Shenqi Pill via Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo”. 2024. Iranian Journal of Kidney Diseases 18 (2): 87-98. https://doi.org/10.52547/ggc27334.